Correspondence 0001062993-23-006216 from Algernon Neuroscience Inc. (CIK 0001959708)

Algernon Neuroscience Inc. (CIK 0001959708)
Date: March 7, 2023 · CIK: 0001959708 · Accession: 0001062993-23-006216

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-12117

Date

March 7, 2023

Author

Form

CORRESP

Company

Algernon Neuroscience Inc. (CIK 0001959708)

Letter

Algernon NeuroScience Inc.: CORRESP - Filed by newsfilecorp.com

Algernon Neuroscience Inc.

400 - 601 West Broadway Vancouver, British Columbia, Canada V5Z 4C2

March 7, 2023

VIA EDGAR

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Jimmy McNamara

Re: Algernon Neuroscience Inc.

Offering Statement on Form 1-A

File No. 024-12117

Ladies and Gentlemen:

On behalf of Algernon Neuroscience Inc. (the "Company"), I hereby request qualification of the above-referenced Offering Statement at 4:00 p.m. Eastern Time on Wednesday, March 8, 2023, or as soon thereafter as is practicable. The participant in the Company's offering received a no objections letter from FINRA on February 8, 2023.

Once the Offering Statement is qualified, please orally confirm the event with our counsel, Sheppard, Mullin, Richter & Hampton LLP, by calling Stephen Cohen at (212) 653-8166.

Sincerely,
Algernon Neuroscience Inc.

Show Raw Text

CORRESP
1
filename1.htm

    Algernon NeuroScience Inc.: CORRESP - Filed by newsfilecorp.com

    Algernon Neuroscience Inc.

    400 - 601 West Broadway
Vancouver, British Columbia, Canada V5Z 4C2

    March 7, 2023

    VIA EDGAR

    United States Securities and Exchange Commission

    100 F Street, N.E.

    Washington, D.C. 20549

    Attention: Mr. Jimmy McNamara

     Re: Algernon Neuroscience Inc.

     Offering Statement on Form 1-A

     File No. 024-12117

    Ladies and Gentlemen:

    On behalf of Algernon Neuroscience Inc. (the "Company"), I hereby request qualification of the above-referenced Offering Statement at 4:00 p.m. Eastern Time on Wednesday, March 8, 2023, or as soon thereafter as is practicable.  The participant in the Company's offering received a no objections letter from FINRA on February 8, 2023.

    Once the Offering Statement is qualified, please orally confirm the event with our counsel, Sheppard, Mullin, Richter & Hampton LLP, by calling Stephen Cohen at (212) 653-8166.

    Sincerely,

    Algernon Neuroscience Inc.

                By:
                /s/ Christopher J. Moreau

                Name:
                Christopher J. Moreau

                Title:
                Chief Executive Officer

SecProbe.io